Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer

Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer


Identification: unj_ma12_08
Issue: March-April 2012
Volume: Volume 32 Number 2

Standard: $15.00

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content

References